The heightened protection observed with this combined approach was associated with increased Mtb32-specific IFN-γ-secreting CD4+ and CD8+ T-cell responses in the lungs and spleens, indicating the potential of IL-7-nFc as a promising adjunct for tuberculosis DNA vaccines in clinical applications [38]. The gene discussed is IFNG; the disease is tuberculosis.